Interim analysis of a phase II study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with Standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy

ubidecarenone IV (BPM31510 IV) - BPGbio

https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal_2/presentation

S. Nagpal1; B. Stockdale1; A. Cohen2; C. Patil3; B. Vaillant4; K. Elmore5; A.J. Brenner6; R. Juthani7; D.A. Reardon8; R. Kendle9; A.I. Spira10; J. Wykretowicz11; V. Zhukova-Harrill12; B. Nie13; N.R. Narain14; V. Modur13

Jul 24, 2025